Amarin Corp Plc (AMRN)

[goamrn]

Huge win indeed! It Will work if AMRN plan to use litigation to delay generics launch. GSK/Teva first infringement litigation was filed July 2014 and it has been 6 years, when Teva is facing severe penalty. I don’t see why Hikma will take the risk to launch and face years of litigation and very possible loss. The most likely outcome will be to settle.

Of course Hikma’s chance will be even lower if AMRN will be BO by a BP. GSK could be waiting to pull the trigger on AMRN after they win against Teva to set case law. BB and JT know this and they just needed to wait.

My prediction: EU recommendation or approval—-GSK offer—-(bid war hopefully, or joint BO)—-price target $36-52.

AIMO